Insider Trading
Current insider transactions (SEC Form 4) — buys and sells by officers, directors, and major shareholders.
| Ticker | Insider | Title | Date | Transaction | Price ($) | Shares | Value ($) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| INCY | Cagnoni Pablo J | President, Global Head of R&D | 08/19/2026 | Verkauf | 125.56 | 10,801 | 1,356,174 | Form 4 |
| INCY | Cagnoni Pablo J | President, Global Head of R&D | 08/12/2026 | Verkauf | 120.04 | 10,803 | 1,296,792 | Form 4 |
| INCY | Mayes Patrick A | EVP & Chief Scientific Officer | 08/05/2026 | Verkauf | 123.99 | 2,207 | 273,646 | Form 4 |
| INCY | Cagnoni Pablo J | President, Global Head of R&D | 08/05/2026 | Verkauf | 122.69 | 10,640 | 1,305,422 | Form 4 |
| INCY | Mayes Patrick A | EVP & Chief Scientific Officer | 08/03/2026 | Verkauf | 120.43 | 6,055 | 729,204 | Form 4 |
| INCY | Mayes Patrick A | EVP & Chief Scientific Officer | 07/31/2026 | Verkauf | 119.41 | 2,293 | 273,807 | Form 4 |
| INCY | Mayes Patrick A | EVP & Chief Scientific Officer | 07/31/2026 | Verkauf | 121.69 | 326 | 39,671 | Form 4 |
| INCY | Mayes Patrick A | EVP & Chief Scientific Officer | 07/31/2026 | Verkauf | 122.19 | 85 | 10,386 | Form 4 |
| INCY | Mayes Patrick A | EVP & Chief Scientific Officer | 07/31/2026 | Verkauf | 119.38 | 1,642 | 196,022 | Form 4 |
| INCY | Mayes Patrick A | EVP & Chief Scientific Officer | 07/31/2026 | Verkauf | 119.51 | 1,643 | 196,355 | Form 4 |
| INCY | Mayes Patrick A | EVP & Chief Scientific Officer | 07/31/2026 | Verkauf | 119.40 | 2,864 | 341,962 | Form 4 |
| INCY | Mayes Patrick A | EVP & Chief Scientific Officer | 07/31/2026 | Verkauf | 119.39 | 4,695 | 560,536 | Form 4 |
| INCY | Mayes Patrick A | EVP & Chief Scientific Officer | 07/31/2026 | Verkauf | 119.43 | 6,171 | 737,003 | Form 4 |
| INCY | Mayes Patrick A | EVP & Chief Scientific Officer | 07/31/2026 | Verkauf | 119.47 | 2,187 | 261,281 | Form 4 |
| INCY | Mayes Patrick A | EVP & Chief Scientific Officer | 07/31/2026 | Verkauf | 119.42 | 5,332 | 636,747 | Form 4 |
| INCY | Mayes Patrick A | EVP & Chief Scientific Officer | 07/31/2026 | Verkauf | 119.46 | 14,661 | 1,751,403 | Form 4 |
| INCY | Cagnoni Pablo J | President, Global Head of R&D | 07/31/2026 | Verkauf | 119.70 | 15,888 | 1,901,794 | Form 4 |
| INCY | Issa Mohamed Khairie | EVP, Head of U.S. Commercial | 07/16/2026 | Verkauf | 115.01 | 1,093 | 125,706 | Form 4 |
| INCY | Stein Steven H | CMO & Head of Late-Stage Dev. | 07/16/2026 | Verkauf | 114.73 | 1,877 | 215,348 | Form 4 |
| INCY | Stein Steven H | CMO & Head of Late-Stage Dev. | 07/15/2026 | Verkauf | 113.05 | 28,237 | 3,192,193 | Form 4 |
A compact market overview — not investment advice. Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q).